Skip to content

The Effect of E-Health Management on Gestational Diabetes Control

Randomized Controlled Trail of e-Health Management for Women With Prior Gestational Diabetes Mellitus

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03726983
Enrollment
112
Registered
2018-11-01
Start date
2017-01-05
Completion date
2018-02-28
Last updated
2018-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gestational Diabetes Mellitus in Pregnancy

Keywords

gestational diabetes mellitus, pregnant women, e-health management, metabolic syndrome

Brief summary

The purpose of this study was to develop an e-heath management platform(eHMP) for women with high risk of gestational diabetes mellitus (GDM) and to evaluate the longitudinal effects between groups of eHMP intervention.

Detailed description

Background: Women with previous gestational diabetes mellitus are at increased risk for developing type2 diabetes mellitus or metabolic syndrome in their later life. Infants of mothers with GDM are more susceptible to stillbirth and more serious health concerns. With limited time for visits and the predicament of education, applying web-based intervention has become a convenient tool for health management. Objectives: The approved project aimed to develop an e-heath management platform(eHMP) for women with high risk of gestational diabetes mellitus (GDM) and to evaluate the longitudinal effects between groups of eHMP intervention. The eHMP integrate GDM health care knowledge, self-awareness of health, self-monitoring of health status (i.e., recording weight and measurement data of metabolic syndrome risk factors and monitoring changes in data trends); participation in discussions or browsing forums; healthy lifestyle guidance and counseling; reminder systems, a token system of earning points in exchange for prizes. Methods: Pregnant women aged 18-45 years with high risk of metabolic syndrome who have a singleton pregnancy, are eligible to participate in this study. Women who agree to participate in the study will be given a participant information sheet and consent form. Participants will be recruited from the Pregnancy diabetes Clinic, at Chang Gung memorial hospital and introduced to the eHMP using the mobile phone in the clinic. Participants will also be given the URL to access to the program and they can learn the modules at home by using their home PCs, mobile phones, or tablets. They were followed up for three times: 28 weeks' gestation, 36-40 weeks' gestation and 6-12 weeks postpartum. SPSS version 20.0 software was used to compile and analyze the research data, including questionnaires and blood test for metabolic index.

Interventions

OTHERExperimental group

Pregnant women who agree to take part will be assigned to a group: experimental group and control group. The experimental group will received health management support and counseling that were conducted by the researchers through the e-health management platform.

Sponsors

Chang Gung Memorial Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

This study was longitudinal approach and repeated testing using an experimental design to evaluate the follow-up outcomes of the e-heath management platform intervention.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

Pregnant women (pre-pregnancy body mass index ≧ 24) must meet at least one of the following conditions and agree to be interviewed: * Age over 34 years old; * Ever had giant infant delivery (weight ≧ 4.5 kg); * Previous diagnosed with gestational diabetes ; * Family history of diabetes.

Exclusion criteria

* Pre-existing diabetes (types 1 and 2); * Unable to write and understand Chinese; * Subject has cognitive impairment; * Subject has intellectual disability or mental illness; * Dependent on medical care (eg, anti-depressants, or any psychiatric medication)

Design outcomes

Primary

MeasureTime frameDescription
Newborn baby weightat birthNewborn baby weight in normal range (\>2500g - \<4500g) - dichotomous outcome Yes/No assessed using calibrated digital scales.
Change of systolic blood pressureChange from Baseline at 6-12 weeks after deliveryNormal systolic blood pressure was \<130mmHg; ≥130mmHg was abnormal. Blood pressure was measured at the right arm twice after a 10-min rest in the supine position by using a calibrated sphygmomanometer and averaged.
Change of diastolic blood pressureChange from Baseline at 6-12 weeks after deliveryNormal diastolic blood pressure was \<85mmHg; ≥85mmHg was abnormal. Blood pressure was measured at the right arm twice after a 10-min rest in the supine position by using a calibrated sphygmomanometer and averaged.
Change of body weightChange from Baseline at 6-12 weeks after deliveryWomen's weight following as assessed using calibrated digital scales
Change of Triglyceride LevelChange from Baseline at 6-12 weeks after deliveryBlood sampling was performed in the fasting state. Normal triglyceride was \<150 mg/dl; ≥150mg/dl was abnormal
Change of Fasting Blood Glucose (FBG) LevelChange from Baseline at 6-12 weeks after deliveryBlood sampling was performed in the fasting state. Normal FBG was \< 100 mg/dl; ≥100mg/dl was abnormal
Change of high-density lipoprotein cholesterol (HDL) levelChange from Baseline at 6-12 weeks after deliveryBlood sampling was performed in the fasting state. Normal HDL was ≥50 mg/dl; \<50mg/dl was abnormal
Change of Cholesterol levelChange from Baseline at 6-12 weeks after deliveryBlood sampling was performed in the fasting state. Normal Cholesterol was \< 200 mg/dl; ≥200mg/dl was abnormal

Secondary

MeasureTime frameDescription
Change of Dietary Behavioral Characteristics ScaleChange from Baseline at 6-12 weeks after deliveryThe instrument is 17-item Likert-type self-report instrument, used a 5-point response format to obtain data regarding the frequency of reported behaviors (never, rarely, sometimes, usually, always). It including two dimensions and each scale range as: balanced diet (5 items, scale range 5-25) and diet control behavior (12 items, scale range 12-60). Higher values represent a better maternal dietary patterns during pregnancy.
Change of Health Promotion ScaleChange from Baseline at 6-12 weeks after deliveryThe instrument is 40-item Likert-type self-report instrument, used a 5-point response format to obtain data regarding the frequency of reported behaviors (never, rarely, sometimes, usually, always). It including six dimensions and each scale range as: social-support (6 items, scale range 6-30), life-appreciation (8 items, scale range 8-40), health-responsibility (8 items, scale range 8-40), stress-management (9 items, scale range 9-45), nutritional behaviors (5 items, scale range 5-25) and exercise behaviors (4 items, scale range 4-20). The total score was 40 to 200, higher values represent a better health promotion lifestyle.
Change of Pregnancy Physical Activity AssessmentChange from Baseline at 6-12 weeks after deliveryThere are 12 items in this questionnaire, including two dimensions: exercise and inactivity. Exercise dimension contained four items to assess the type of physical activity, intensity, duration, frequency during pregnancy. At least 3 days per week, and each time at least 20-30 minutes, counted as regular exercise (dichotomous outcome Yes/No assessed). Inactivity dimension contained 8 items, dichotomous outcome Yes/No assessed (score 0-8), higher values represent an inactivity lifestyle.

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026